North America Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel

List of Tables

The North America transdermal medical patch market is expected to grow from US$ 3,498.63 million in 2023 to US$ 4,324.69 million by 2028. It is estimated to register a CAGR of 4.3% from 2023 to 2028.

Growing Consumption of Tobacco Fuels North America Transdermal Medical Patch Market

In the US, tobacco is one of the significant causes of disease, disability, and death. According to the data published by CDC in 2021, an estimated 28.3 million adults smoke cigarettes in the US. Nearly 1,600 people (younger than 18 years) smoke their first cigarette every day in the US, and nearly half a million Americans die prematurely due to secondhand smoke exposure. As per the same source, e-cigarettes are the most frequently used tobacco products among high and middle school students. CDC also states that the US spends more than US$ 225 billion on medical care each year to treat smoking-related diseases in adults.

Nicotine replacement therapy (NRT) has proven to help people seeking to quit smoking. It makes use of nicotine patches that deliver modest nicotine dosages to relieve cravings. Nicotine is progressively absorbed through the skin once nicotine patches are applied. Smokers with a greater dependence level can use the most robust patches, while those with a lower dependence level can use a lesser dosage. The critical advantage of nicotine patches over acute NRT formulations (gum, nasal spray, oral inhaler, and tablet) is the simplicity of compliance, rather than consuming a medicine throughout the day.

Thus, the increasing consumption of tobacco leads to increasing demand for nicotine patches, thereby driving the growth of the transdermal medical patch market.

North America Transdermal Medical Patch Market Overview

The North American transdermal medical patch market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America transdermal medical patch market. The rising number of patients suffering from chronic conditions and increasing activities in research and development are the key factors propelling the market for transdermal medical patches.

North America Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

North America Transdermal Medical Patch Market Segmentation

The North America transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share in 2023.

Based on application, the market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the North America transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the North America transdermal medical patch market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.

Boehringer Ingelheim International GmbH, Corium, LLC, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America transdermal medical patch market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00028759

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Transdermal Medical Patch Market - by Type
- 1.3.2 North America Transdermal Medical Patch Market - by Application
- 1.3.3 North America Transdermal Medical Patch Market - by Distribution Channel
- 1.3.4 North America Transdermal Medical Patch Market - by Country

2. Transdermal Medical Patch Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Transdermal Medical Patch Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Expert's Opinion

5. North America Transdermal Medical Patch Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Consumption of Tobacco
5.2 Market Restraints
- 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
5.3 Market Opportunities
- 5.3.1 Increasing Strategic Initiatives
5.4 Future Trends
- 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
5.5 Impact analysis

6. Transdermal Medical Patch Market - North America Analysis

6.1 North America Transdermal Medical Patch Market Revenue Forecast and Analysis

7. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type

7.1 Overview
7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
7.3 Single-Layer Drug In-Adhesive
- 7.3.1 Overview
- 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multi-Layer Drug In-Adhesive
- 7.4.1 Overview
- 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Reservoir
- 7.5.1 Overview
- 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Vapor Patch
- 7.6.1 Overview
- 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Matrix
- 7.7.1 Overview
- 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application

8.1 Overview
8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
8.3 Neurologic Conditions
- 8.3.1 Overview
- 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Pain Management
- 8.4.1 Overview
- 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Nicotine Cessation
- 8.5.1 Overview
- 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiovascular Disorders
- 8.6.1 Overview
- 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Hormonal Therapy
- 8.7.1 Overview
- 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels

9.1 Overview
9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
- 9.4.1 Overview
- 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Online Pharmacies
- 9.5.1 Overview
- 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis

10.1 North America: Transdermal Medical Patch Market
- 10.1.1 The Overview
- 10.1.2 North America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 US: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.1.4 US: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.1.5 US: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.2 Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Canada: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.2.4 Canada: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.2.5 Canada: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
  - 10.1.2.3 Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Mexico: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
    - 10.1.2.3.4 Mexico: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
    - 10.1.2.3.5 Mexico: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies
- 11.2.1 Overview

12. Company Profiles

12.1 Hisamitsu Pharmaceutical Co Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Medline Industries LP
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Johnson & Johnson
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Novartis AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 UCB SA
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Viatris Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Endo Pharmaceuticals Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Corium, LLC.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms